Neurocrine Biosciences Inc (NASDAQ:NBIX) has 706 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 13,385,607 | 555,010 | 4.33% | $1,763,419,855.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 12,830,597 | 124,367 | 0.98% | $1,819,763,595.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 9,700,301 | -6,258 | -0.06% | $1,375,793,692.00 |
| DODGE & COX | 31 Mar, 2026 | 5,508,042 | -48,576 | -0.87% | $781,205,597.00 |
| DODGE & COX | 31 Mar, 2026 | 5,461,037 | -47,005 | -0.85% | $719,437,014.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 5,442,067 | 241,711 | 4.65% | $700,502,972.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 5,200,356 | -4,259,948 | -45.03% | $737,566,619.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,938,967 | 1,667,261 | 50.96% | $650,659,396.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,726,344 | 4,726,344 | 0.00% | $622,648,559.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,511,904 | 4,511,904 | 0.00% | $594,398,233.00 |
| State Street Corp | 31 Mar, 2026 | 4,354,526 | 111,845 | 2.64% | $573,665,255.00 |
| State Street Corp | 31 Mar, 2026 | 4,242,681 | -103,798 | -2.39% | $601,739,446.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,271,706 | 498,058 | 17.96% | $462,651,883.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 3,060,570 | 2,075,759 | 210.78% | $403,199,492.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 2,418,897 | 180,100 | 8.04% | $318,665,491.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 2,238,797 | -179,500 | -7.42% | $317,528,579.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,136,672 | 77,390 | 3.76% | $280,802,611.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,059,282 | 34,457 | 1.70% | $291,341,652.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 1,744,560 | -67,202 | -3.71% | $247,430,944.00 |
| Bellevue Group AG | 31 Mar, 2026 | 1,703,304 | -59,801 | -3.39% | $241,579,606.00 |